STOCK TITAN

Over-allotment adds cash for Collective Acquisition II (NASDAQ: CAIIU)

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Collective Acquisition Corp. II reports that underwriters fully exercised their option to purchase 3,300,000 additional units at $10.00 each, adding gross proceeds of $33,000,000. Including this over-allotment, the company has sold 25,300,000 units for total gross proceeds of $253,000,000 and issued 6,250,000 private placement warrants for $5,000,000.

The company states that $254,265,000 of net proceeds from the IPO, over-allotment units and private placements was deposited into its trust account for the benefit of public shareholders. It also announced that beginning June 22, 2026, holders may separately trade Class A ordinary shares under “CAII” and warrants under “CAIIW,” while units continue under “CAIIU.”

Positive

  • None.

Negative

  • None.

Insights

Routine SPAC over-allotment exercise adds trust cash and sets up separate trading.

Collective Acquisition Corp. II confirms a standard SPAC milestone: the underwriters fully exercised their 3,300,000-unit over-allotment at $10.00 per unit, plus an extra 412,500 private placement warrants to the sponsor. This brings total IPO units to 25,300,000 and private placement warrants to 6,250,000.

Net proceeds of $254,265,000 were placed in the trust account for public shareholders, aligning with typical SPAC structures that protect redemption value. The filing also details additional deferred underwriting fees and representative shares, which modestly increase dilution but are standard for this vehicle.

The announcement that, starting June 22, 2026, units can split into separately trading Class A shares (CAII) and warrants (CAIIW) marks the transition to normal post-IPO trading. Subsequent disclosures about any business combination will further clarify how this capital is deployed.

Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Over-allotment units 3,300,000 units at $10.00 Underwriters’ option exercised on June 12, 2026
Additional gross proceeds $33,000,000 From 3,300,000 over-allotment units
Total IPO units sold 25,300,000 units Including over-allotment option units
Total private placement warrants 6,250,000 warrants IPO plus over-allotment private placements
Private placement proceeds $5,000,000 6,250,000 warrants at $0.80 each
Trust account balance $254,265,000 Net proceeds from IPO, over-allotment and private placements
Warrant exercise price $11.50 per share Each whole warrant for one Class A ordinary share
Separate trading start date June 22, 2026 Units can split into CAII and CAIIW
over-allotment option financial
"the Underwriters exercised the Over-Allotment Option in full, and the closing of the issuance and sale of the additional Units"
An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.
Private Placement Warrants financial
"the Company consummated the private placement with the Sponsor of 5,837,500 warrants (the “Private Placement Warrants”)"
Private placement warrants are tradable coupons given directly to a limited group of investors that let the holder buy a company's shares at a fixed price before a set expiration date. They matter to investors because they can provide extra upside if the stock rises and give companies a way to raise money outside a public offering, but they also can increase the number of shares outstanding (dilution) and therefore affect share value and investor returns.
Class A ordinary shares subject to possible redemption financial
"Class A ordinary shares subject to possible redemption, $0.0001 par value; 25,300,000 shares at redemption value of $10.05 per share"
Trust Account financial
"was deposited in the Company’s trust account established for the benefit of the Company’s public shareholders"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
deferred underwriting fee financial
"To record the accrual of deferred underwriting fee on over-allotment option."
forward-looking statements regulatory
"This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements”"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0002115404 0002115404 2026-06-12 2026-06-12 0002115404 CAIIU:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember 2026-06-12 2026-06-12 0002115404 CAIIU:ClassOrdinarySharesParValue0.0001PerShareMember 2026-06-12 2026-06-12 0002115404 CAIIU:WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember 2026-06-12 2026-06-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 12, 2026

 

Collective Acquisition Corp. II

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-43255   98-1924367
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1000 Brickell Avenue

Ste 715 PMB 5110

Miami, Florida 33131

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (561) 489-2062

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant   CAIIU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   CAII   The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share   CAIIW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 3.02. Unregistered Sales of Equity Securities.

The information set forth in Item 8.01 below is incorporated into this Item 3.02 by reference.

Item 8.01. Other Events.

As previously disclosed on a Current Report on Form 8-K dated May 4, 2026 (the “IPO Closing 8-K”), Collective Acquisition Corp. II (the “Company”) consummated its initial public offering (the “IPO”) of 22,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share (each, a “Warrant”). The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $220,000,000. The Company granted Clear Street LLC, as representative of the several underwriters (collectively, the “Underwriters”), a 45-day option to purchase up to 3,300,000 additional Units to cover over-allotments, if any (the “Over-Allotment Option”).

As previously disclosed in the IPO Closing 8-K, simultaneously with the closing of the IPO, the Company consummated the private placement (the “IPO Private Placement”) with Collective Acquisition Sponsor II LLC (the “Sponsor”) of 5,837,500 warrants (the “Private Placement Warrants”), at a price of $0.80 per Private Placement Warrant, generating gross proceeds of $4,670,000. The Private Placement Warrants were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), as the transaction did not involve a public offering.

As previously disclosed in the IPO Closing 8-K, the Company also issued in a private placement to the Underwriters 165,000 Class A Ordinary Shares upon the consummation of the IPO (the “Representative Shares”). The Representative Shares are identical to the Class A Ordinary Shares included in the Units, except that these securities may not be sold, transferred, assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person, for a period of 180 days from the date of the IPO except as permitted under FINRA Rule 5110(e)(2). The Underwriters have agreed not to transfer, assign or sell any Representative Shares without the Company’s prior written consent until the completion of the Company’s initial business combination. In addition, the Underwriters have agreed (i) to waive their conversion rights (or right to participate in any tender offer) with respect to the Representative Shares in connection with the completion of the initial business combination, (ii) to waive their redemption rights with respect to the Representative Shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete its initial business combination within 18 months from the closing of the IPO or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, and (iii) to waive their rights to liquidating distributions from the Company’s trust account with respect to the Representative Shares if the Company fails to complete its initial business combination within 18 months from the closing of the IPO. The issuance of the Representative Shares was made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, as the transaction did not involve a public offering.

Subsequently, on June 11, 2026, the Underwriters exercised the Over-Allotment Option in full, and the closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on June 12, 2026. The aggregate issuance by the Company of 3,300,000 Over-Allotment Option Units at a price of $10.00 per Unit resulted in additional gross proceeds of $33,000,000. On June 12, 2026, simultaneously with the sale of the Over-Allotment Option Units, the Company consummated the private sale of an additional 412,500 Private Placement Warrants to the Sponsor (the “Over-Allotment Private Placement Warrants”), generating gross proceeds of $330,000 (the “Over-Allotment Private Placement,” together with the IPO Private Placement, the “Private Placements”). The Over-Allotment Private Placement Warrants were issued pursuant to Section 4(a)(2) of the Securities Act, as the transaction did not involve a public offering. Simultaneously with the sale of the Over-Allotment Option Units and the Over-Allotment Private Placement Warrants, the Company issued an additional 24,750 Representative Shares to the Underwriters on the same terms and conditions as the Representative Shares issued in connection with the IPO. Including the Over-Allotment Option Units, the Company has now sold a total of 25,300,000 Units, generating total gross proceeds of $253,000,000, and a total of 6,250,000 Private Placement Warrants, generating total gross proceeds of $5,000,000.

1

 

 

A total of $254,265,000 of the net proceeds from the sale of the Units in the IPO (including the Over-Allotment Option Units) and the Private Placements (including the Over-Allotment Private Placement Warrants) was deposited in the Company’s trust account established for the benefit of the Company’s public shareholders, with Efficiency INC. acting as trustee. An unaudited pro forma balance sheet as of June 12, 2026, reflecting receipt of the proceeds received by the Company in connection with the consummation of the IPO (including the Over-Allotment Option Units) and the Private Placements (including the Over-Allotment Private Placement Warrants), is included in this Current Report on Form 8-K as Exhibit 99.1.

Separate Trading of Class A Ordinary Shares and Warrants

On June 17, 2026, the Company issued a press release announcing that, commencing on June 22, 2026, the holders of the Units may elect to separately trade the Class A Ordinary Shares and the Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Class A Ordinary Shares and the Warrants are expected to trade on the Nasdaq Global Market under the symbols “CAII” and “CAIIW,” respectively. Units not separated will continue to trade on the Nasdaq Global Market under the symbol “CAIIU.” Holders of Units will need to have their brokers contact Efficiency INC., the Company’s transfer agent, in order to separate the Units into Class A Ordinary Shares and Warrants.

A copy of the press release is attached as Exhibit 99.2 hereto and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.   Description
99.1   Unaudited pro forma balance sheet of Collective Acquisition Corp. II as of June 12, 2026.
99.2   Press release dated June 17, 2026.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  COLLECTIVE ACQUISITION CORP. II
     
  By: /s/ Daniel Hoffman
  Name: Daniel Hoffman
  Title: Chief Executive Officer
     
Dated: June 17, 2026    

 

3

 

Exhibit 99.1

 

COLLECTIVE ACQUISITION CORP. II

PROFORMA UNAUDITED BALANCE SHEET

 

  

April 30,

2026

   Pro Forma Adjustments (Unaudited)     As Adjusted (Unaudited) 
Assets              
Current assets              
Cash  $1,031,745    (82,500) (5)  $949,245 
Prepaid expenses and insurance   155,100           155,100 
Total current assets   1,186,845           1,104,345 
Long-term prepaid insurance   77,500           77,550 
Cash held in Trust Account   221,100,000    33,000,000  (1)   254,265,000 
         330,000  (2)     
         (247,500) (3)     
         82,500  (5)     
Total Assets  $222,364,395    33,165,000     $255,446,895 
                  
Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit                 
Current Liabilities                 
Accrued expenses  $2,500          $2,500 
Accrued offering costs   75,366           75,366 
Over-allotment option liability   173,701    (173,701) (6)    
Total Current Liabilities   251,567    (173,701)     77,866 
Deferred underwriting fee payable   6,600,000    990,000  (4)   7,590,000 
Total Liabilities   6,851,567    816,299      7,667,866 
                  
Commitments and Contingencies (Note 6)                 
Class A Ordinary Shares subject to Possible Redemption                 
Class A ordinary shares subject to possible redemption, $0.0001 par value; 25,300,000 shares at redemption value of $10.05 per share   221,100,000    32,692,000  (1)   254,265,000 
         (245,190) (3)     
         (980,760) (4)     
         (239,364) (7)     
         1,938,314  (8)     
                  
Shareholders’ Deficit:                 
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding               
Class A ordinary shares, $0.0001 par value; 300,000,000 shares authorized; 189,750 shares issued and outstanding (excluding 25,300,000 shares subject to possible redemption)   17    2  (6)   19 
Class B ordinary shares, $0.0001 par value; 30,000,000 shares authorized; 8,433,333 shares issued and outstanding(1)   843           843 
Additional paid-in capital       308,000  (1)    
         330,000  (2)     
         (2,310) (3)     
         (9,240) (4)     
         (4,671) (7)     
         244,033  (7)     
         (1,938,314) (8)     
         1,072,502  (9)     
                  
Accumulated deficit   (5,588,032)   173,701  (6)   (6,486,833)
         (1,072,502) (9)     
Total Shareholders’ Deficit  $(5,587,172)   (898,799)    $(6,485,971)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit  $222,364,395    32,609,500     $255,446,895 

 

 

(1) Includes up to 1,100,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. As a result of the full exercise of the over-allotment option, 1,100,000 Founder Shares no longer subject to forfeiture. (see Note 7).

 

See Note to Pro Forma Unaudited Balance Sheet.

 

 

 

COLLECTIVE ACQUISITION CORP. II

NOTES TO PROFORMA UNAUDITED BALANCE SHEET

(Unaudited)

 

Note 1 - Closing of over-allotment option and additional private placement

 

The accompanying unaudited proforma balance sheet presents the balance sheet of Collective Acquisition Corp. II (the “Company”) as of April 30, 2026 adjusted for the closing of the underwriters’ overallotment option and related transactions, which occurred on June 12, 2026, as described below.

 

On April 30, 2026, the Company consummated the initial public offering (the “Initial Public Offering”) of 22,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $220,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 5,837,500 private placement warrants (the “Private Placement Warrants”) at a price of $0.80 per Private Placement Warrant, in a private placement to the Company’s Sponsor, generating gross proceeds of $4,670,000. Each Unit consists of one Class A Ordinary Share, par value $0.0001 per share, and one-half of one redeemable warrant (the “Public Warrants”), each whole Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, subject to adjustment.

 

In connection with the Initial Public Offering, the underwriters were granted a 45-day option from the date of the Initial Public Offering to purchase up to an additional 3,300,000 Units to cover over-allotments if any. On June 12, 2026, the underwriters exercised their over-allotment option in full to purchase an additional 3,300,000 Units at $10.00 per Unit, generating gross proceeds of $33,000,000. As a result of the full exercise of the over-allotment option, 1,100,000 Founder Shares no longer subject to forfeiture.

 

As of June 12, 2026, a total of $33,165,000 of the net proceeds from the Initial Public Offering (including the full over-allotment close) and the sale of the Private Placement Warrants were placed in the trust account (the “Trust Account”).

 

Pro forma adjustments to reflect the full exercise of the underwriters’ over-allotment option are as follows:

 

    Pro forma entry                
1   Cash held in Trust Account   $ 33,000,000          
    Class A ordinary shares subject to possible redemption           $ 32,692,000  
    Additional paid-in capital             308,000  
    To record the sale of 3,300,000 IPO over-allotment units at $10.00 per unit.                
                     
2   Cash held in Trust Account   $ 330,000          
    Additional paid-in capital           $ 330,000  
    To record sale of 412,500 additional Private Placement Warrants to Sponsor at $0.80 per Private Placement Warrant                
                     
3   Class A ordinary shares subject to possible redemption   $ 245,190          
    Additional paid-in capital     2,310          
    Cash held in Trust Account           $ 247,500  
    To record additional cash underwriting fees                
                     
4   Class A ordinary shares subject to possible redemption   $ 980,760          
    Additional paid-in capital     9,240          
    Deferred underwriting fee           $ 990,000  
    To record the accrual of deferred underwriting fee on over-allotment option.                
                     
5   Cash held in Trust Account   $ 82,500          
    Cash           $ 82,500  
    To record additional funding into the Trust Account                
                     
6   Over-allotment option liability   $ 173,701          
    Accumulated deficit           $ 173,701  
    To close OA option liability for the exercised over-allotment option of 3,300,000 units                
                     
7   Class A ordinary shares subject to possible redemption   $ 239,364          
    Additional paid-in capital     4,671          
    Class A ordinary shares           $ 2  
    Additional paid-in capital             244,033  
    To record fair value of additional representative shares issued at IPO due to full exercise of OA option units                
                     
8   Additional paid-in capital   $ 1,938,314          
    Class A ordinary shares subject to possible redemption           $ 1,938,314  
    Record accretion of ordinary shares subject to redemption an amount of $10.05 per share.                
                     
9   Accumulated deficit   $ 1,072,502          
    Additional paid-in capital           $ 1,072,502  
    Reclassify negative additional paid in capital to accumulated deficit.                

 

 

Exhibit 99.2

 

Collective Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 22, 2026

Miami, FL, June 17, 2026 (GLOBE NEWSWIRE) -- Collective Acquisition Corp. II (Nasdaq: CAIIU) (the “Company”) announced today that, commencing June 22, 2026, holders of the units issued in the Company’s initial public offering (the “Units”), each consisting of one Class A ordinary share of the Company (the “Class A Ordinary Shares”) and one-half of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, may elect to separately trade the Class A Ordinary Shares and Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Class A Ordinary Shares and Warrants will trade on the Nasdaq Global Market under the symbols “CAII” and “CAIIW,” respectively. Units not separated will continue to trade on the Nasdaq Global Market under the symbol “CAIIU.”

Clear Street LLC acted as sole book-running manager for the offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Collective Acquisition Corp. II

Collective Acquisition Corp. II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any industry, sector or geographic region but intends to focus its search initially on businesses that provide products or services impacting the sovereignty, security, self-sufficiency, or other national interests of the United States and/or its allies, including in the financial, strategic resources, defense technology, or artificial intelligence sectors.

The Company’s management team is led by Daniel Hoffman, its Chief Executive Officer, and Samuel Sayegh, its Chairman, President and Chief Financial Officer, who are both members of the Board of Directors of the Company (the “Board”). In addition, the Board includes Rear Admiral (Ret.) Matthew Burns, Lieutenant General (Ret.) Francis Beaudette, and James Shekerdemian.

FORWARD-LOOKING STATEMENTS

This press release may include, and oral statements made from time to time by representatives of the Company may include, “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company’s filings with the Securities and Exchange Commission (“SEC”). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Company’s initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

 

Investor Contacts

Collective Acquisition Corp. II

Daniel Hoffman, Chief Executive Officer

dan@ccmacq.com

FAQ

What over-allotment units did Collective Acquisition Corp. II (CAIIU) issue?

Collective Acquisition Corp. II issued 3,300,000 over-allotment option units at $10.00 per unit, generating additional gross proceeds of $33,000,000. This increased total IPO units sold to 25,300,000, as disclosed in the pro forma balance sheet and 8-K narrative.

How much cash did Collective Acquisition Corp. II (CAIIU) place in its trust account?

The company deposited $254,265,000 of net proceeds into its trust account. This amount reflects funds from the IPO units, the fully exercised over-allotment option, and both private placements of warrants, all for the benefit of public shareholders.

When will CAIIU units begin separate trading of shares and warrants?

Separate trading of Class A ordinary shares and warrants begins June 22, 2026. After that date, Class A shares trade as “CAII,” warrants as “CAIIW,” while units not separated continue trading on the Nasdaq Global Market under the symbol “CAIIU.”

What private placement warrants did Collective Acquisition Corp. II (CAIIU) sell?

The company sold 5,837,500 private placement warrants at $0.80 each at IPO and an additional 412,500 upon over-allotment closing. In total, 6,250,000 private placement warrants were issued, generating aggregate gross proceeds of $5,000,000 to the company.

What is the exercise price of Collective Acquisition Corp. II (CAIIU) warrants?

Each whole redeemable warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share. Warrants are included in the units and, after separation, will trade on the Nasdaq Global Market under the symbol “CAIIW.”

How many representative shares did the CAIIU underwriters receive?

Underwriters received 165,000 Class A representative shares at IPO and 24,750 additional representative shares upon full over-allotment exercise. These shares match the public Class A shares but are subject to transfer restrictions and waiver of redemption and liquidation rights.

Filing Exhibits & Attachments

6 documents